A majority of studies have confirmed the relationship between Lp-PLA2 mass and/or activity levels and the risk of subsequent cardiovascular diseases (CVD), but investigations of Lp-PLA2 mass and/or activity levels and the risk of stroke have produced conflicting results. This evidence concerns the gene PLA2G7 and stroke disorder.